Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL)
暂无分享,去创建一个
Y. Chawla | S. Fan | M. Yuen | H. Garg | B. Sharma | S. Sarin | S. Hamid | P. Komolmit | Q. Ning | A. Rastogi | S. Rahman | D. Samuel | Ashish Kumar | John A. Almeida | H. J. Silva | R. Jalan | G. Lau | Qing Liu | K. Madan | R. Mohamed | S. Riordan | P. Sakhuja | Samir A. Shah | Praveen Sharma | Y. Takikawa | B. Thapa | C. Wai | Shiv Kumar | B. C. Sharma | Ashish Kumar | B. R. Thapa | S. Fan | H. J. de Silva | S. Hamid | G. Lau | Y. K. Chawla | Shiv Kumar | Sarin Ae | Ashish Kumar | J. A. Almeida | Ae Yogesh | Kumar Chawla | Sheung Tat | Fan Ae | Ae H Janaka De | Silva Ae | Saeed Sadiq | Hamid Ae | Ae Piyawat | Komolmit Ae | Ae Qing | Liu Ae | K. Madan | Ae Rosmawati | Mohamed Ae | Ae Salimur | Rahman Ae | Ae Stephen | M. Riordan | Ae Didier | Samuel Ae | Ae Barjesh | Chander Sharma | Ae Praveen | Sharma Ae | Ae Babu | Ram Thapa | Ae Chun-Tao | Wai Ae | Á. H. Garg | Á. B. C. Sharma | Á. P. Sharma | P. Sharma | A. Kumar | Á. K. Madan | Á. S. M. Riordan | S. M. Riordan | S. T. Fan | H. J. De Silva | P. Komolmit | Ashish Kumar | John A. Almeida | Y. K. Chawla | Sheung Tat Fan | H. Janaka Silva | Qing Liu | Kaushal Madan | Rosmawati Mohamed | Salimur Rahman | Stephen M. Riordan | Didier Samuel | Praveen Sharma | Chun-Tao Wai | Sarin Ae | J. A. Almeida | Ae Yogesh | Kumar Chawla | Sheung Tat | Fan Ae | Ae H Janaka De | Silva Ae | Saeed Sadiq | Hamid Ae | Ae Piyawat | Komolmit Ae | Ae Qing | Liu Ae | Ae Rosmawati | Mohamed Ae | Ae Salimur | Rahman Ae | Ae Stephen | M. Riordan | Ae Didier | Samuel Ae | Ae Barjesh | Chander Sharma | Ae Praveen | Sharma Ae | Ae Babu | Ram Thapa | Ae Chun-Tao | Wai Ae | Á. H. Garg | Á. B. C. Sharma | Á. P. Sharma | P. Sharma | Á. K. Madan | Á. S. M. Riordan | S. M. Riordan | S. T. Fan | H. J. De Silva | P. Komolmit | Shiv Kumar | Sarin Ae | Ashish Kumar | J. A. Almeida | Ae Yogesh | Kumar Chawla | Sheung Tat | Fan Ae | Ae H Janaka De | Silva Ae | Saeed Sadiq | Hamid Ae | Ae Piyawat | Komolmit Ae | Ae Qing | Liu Ae | Ae Rosmawati | Mohamed Ae | Ae Salimur | Rahman Ae | Ae Stephen | M. Riordan | Ae Didier | Samuel Ae | Ae Barjesh | Chander Sharma | Ae Praveen | Sharma Ae | Ae Babu | Ram Thapa | Ae Chun-Tao | Wai Ae | Á. H. Garg | Á. B. C. Sharma | Á. P. Sharma | Á. K. Madan | Á. S. M. Riordan | S. M. Riordan | S. T. Fan | H. J. De Silva | P. Komolmit
[1] J. Bernuau,et al. Fulminant and Subfulminant Liver Failure: Definitions and Causes , 1986, Seminars in liver disease.
[2] A. Gimson,et al. Late onset hepatic failure: Clinical, serological and histological features , 1986, Hepatology.
[3] N. Rolando,et al. Prospective study of bacterial infection in acute liver failure: An analysis of fifty patients , 1990, Hepatology.
[4] G. Alexander,et al. Fungal infection: a common, unrecognised complication of acute liver failure. , 1991, Journal of hepatology.
[5] Roger Williams,et al. Acute liver failure: redefining the syndromes , 1993, The Lancet.
[6] M. Andreu,et al. Risk factors for spontaneous bacterial peritonitis in cirrhotic patients with ascites. , 1993, Gastroenterology.
[7] W. Jiménez,et al. Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites. , 1993, Gastroenterology.
[8] H. Moriwaki,et al. [Acute-on-chronic liver failure]. , 1995, Ryoikibetsu shokogun shirizu.
[9] D. Samuel,et al. Liver transplantation for severe acute liver failure after herbal medicine (Teucrium polium) administration. , 1995, Journal of hepatology.
[10] E. Elias,et al. Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine , 1996, Hepatology.
[11] G. O’Keefe,et al. Morbid prognostic features in patients with chronic liver failure undergoing nonhepatic surgery. , 1997, Archives of surgery.
[12] D. Webb,et al. Peripheral vascular tone in patients with cirrhosis: role of the renin-angiotensin and sympathetic nervous systems. , 1998, Cardiovascular research.
[13] H. Tilg,et al. Cytokines in alcoholic and nonalcoholic steatohepatitis. , 2000, The New England journal of medicine.
[14] J. Bosch,et al. Complications of cirrhosis. I. Portal hypertension. , 2000, Journal of hepatology.
[15] S. Saab,et al. Successful orthotopic liver transplantation for lamivudine-associated YMDD mutant hepatitis B virus. , 2000, Gastroenterology.
[16] C. Zauner,et al. Short‐term prognosis in critically ill patients with liver cirrhosis: an evaluation of a new scoring system , 2000, European journal of gastroenterology & hepatology.
[17] T. Risler,et al. Improvement of hepatorenal syndrome with extracorporeal albumin dialysis mars: Results of a prospective, randomized, controlled clinical trial , 2000, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[18] Roger Williams,et al. The systemic inflammatory response syndrome in acute liver failure , 2000, Hepatology.
[19] O. Ciccarelli,et al. Favorable outcome of orthotopic liver transplantation in a patient with subacute liver failure due to the emergence of a hepatitis B YMDD escape mutant virus. , 2001, Journal of hepatology.
[20] E. Hahn,et al. Short‐term prognosis in critically ill patients with cirrhosis assessed by prognostic scoring systems , 2001, Hepatology.
[21] Roger Williams,et al. Acute-on-Chronic Liver Failure: Pathophysiological Basis of Therapeutic Options , 2002, Blood Purification.
[22] Massimo Malago,et al. Albumin dialysis in cirrhosis with superimposed acute liver injury: A prospective, controlled study , 2002, Hepatology.
[23] K. Reinhart,et al. Prognostic value of the indocyanine green plasma disappearance rate in critically ill patients. , 2002, Chest.
[24] Sheng-Nan Lu,et al. Lamivudine for the treatment of hepatitis B virus reactivation following chemotherapy for non‐Hodgkin's lymphoma , 2002, British journal of haematology.
[25] Rajiv Jalan,et al. The pathophysiological basis of acute-on-chronic liver failure. , 2002, Liver.
[26] S. Hamid,et al. Hepatitis E virus superinfection in patients with chronic liver disease , 2002, Hepatology.
[27] S. Fan,et al. Live-donor liver transplantation for acute-on-chronic hepatitis B liver failure , 2003, Transplantation.
[28] A. Alberti,et al. Hepatitis reactivation and liver failure in haemopoietic stem cell transplants for hepatitis B virus (HBV)/hepatitis C virus (HCV) positive recipients: a retrospective study by the Italian group for blood and marrow transplantation , 2003, Bone Marrow Transplantation.
[29] M. Serra,et al. Risk Factors for Nonhepatic Surgery in Patients with Cirrhosis , 2003, World Journal of Surgery.
[30] S. Mitzner,et al. Economic evaluation and 1‐year survival analysis of MARS in patients with alcoholic liver disease , 2003, Liver international : official journal of the International Association for the Study of the Liver.
[31] Hong-yu Zhang,et al. Application of Molecular Adsorbents Recirculating System to remove NO and cytokines in severe liver failure patients with multiple organ dysfunction syndrome , 2003, Liver international : official journal of the International Association for the Study of the Liver.
[32] A. Naso,et al. CYTOCHINES AND LIVER FAILURE: MODIFICATION OF TNF-a AND IL-6 IN PATIENTS WITH ACUTE ON CHRONIC LIVER DECOMPENSATION TRETED WITH MOLECULAR ADSORBENT RECYCLING SYSTEM (MARS) , 2004 .
[33] R. Bañares,et al. Hepatic and systemic haemodynamic changes after MARS in patients with acute on chronic liver failure , 2003, Liver international : official journal of the International Association for the Study of the Liver.
[34] Q. Ning,et al. The Fgl2/fibroleukin prothrombinase contributes to immunologically mediated thrombosis in experimental and human viral hepatitis. , 2003, The Journal of clinical investigation.
[35] G. Kang,et al. Hepatitis E superinfection produces severe decompensation in patients with chronic liver disease , 2004, Journal of gastroenterology and hepatology.
[36] M. Serra,et al. Plasma concentrations of nitric oxide and asymmetric dimethylarginine in human alcoholic cirrhosis. , 2004, Journal of hepatology.
[37] S. Garg,et al. Superimposed acute hepatitis E infection in patients with chronic liver disease. , 2004, Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology.
[38] M. Khuroo,et al. Molecular adsorbent recirculating system for acute and acute‐on‐chronic liver failure: A meta‐analysis , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[39] Xiao-wei Xu,et al. Effect of artificial liver support system on patients with severe viral hepatitis: a study of four hundred cases. , 2004, World journal of gastroenterology.
[40] Q. Ning,et al. Fibrinogen-like protein 2 fibroleukin expression and its correlation with disease progression in murine hepatitis virus type 3-induced fulminant hepatitis and in patients with severe viral hepatitis B. , 2005, World journal of gastroenterology.
[41] R. D. de Man,et al. Flares in chronic hepatitis B patients induced by the host or the virus? Relation to treatment response during Peg-interferon α-2b therapy , 2005, Gut.
[42] P. Faybik,et al. Pathophysiological effects of albumin dialysis in acute-on-chronic liver failure: a randomized controlled study , 2005, European Surgery.
[43] Kan-Hoe Lee,et al. Outcome from molecular adsorbent recycling system (MARS™) liver dialysis following drug‐induced liver failure , 2005, Liver international : official journal of the International Association for the Study of the Liver.
[44] William M. Lee,et al. AASLD Position Paper: The Management of Acute Liver Failure: Update 2011 , 2011 .
[45] C. Zauner,et al. Outcome prediction for patients with cirrhosis of the liver in a medical ICU: A comparison of the APACHE scores and liver-specific scoringsystems , 1996, Intensive Care Medicine.
[46] Wei Xu,et al. Effects of artificial liver support system on patients with acute or chronic liver failure. , 2005, Transplantation proceedings.
[47] G. Gerken,et al. Removal of Metabolites, Cytokines and Hepatic Growth Factors by Extracorporeal Liver Support in Children , 2005, Journal of pediatric gastroenterology and nutrition.
[48] S. Bae,et al. Preconditioning by extracorporeal liver support (MARS) of patients with cirrhosis and severe liver failure evaluated for living donor liver transplantation – a pilot study , 2005, Liver international : official journal of the International Association for the Study of the Liver.
[49] F. Lammert,et al. Patients with acute on chronic liver failure display "sepsis-like" immune paralysis. , 2005, Journal of hepatology.
[50] P. Collinson,et al. Utility of admission cardiac troponin and “Ischemia Modified Albumin” measurements for rapid evaluation and rule out of suspected acute myocardial infarction in the emergency department , 2006, Emergency Medicine Journal.
[51] C. Derancourt,et al. Late lethal hepatitis B virus reactivation after rituximab treatment of low‐grade cutaneous B‐cell lymphoma , 2006, The British journal of dermatology.
[52] Peter Krisper,et al. Effect of extracorporeal liver support by MARS and Prometheus on serum cytokines in acute-on-chronic liver failure , 2006, Critical care.
[53] M. Serra,et al. Accumulation of Symmetric Dimethylarginine in Hepatorenal Syndrome , 2006, Experimental biology and medicine.
[54] F. Nevens,et al. Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure , 2006, Critical care.
[55] P. Collinson,et al. Ischemia-modified albumin predicts mortality in ESRD. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[56] E. Cholongitas,et al. Risk factors, Sequential Organ Failure Assessment and Model for End‐stage Liver Disease scores for predicting short term mortality in cirrhotic patients admitted to intensive care unit , 2006, Alimentary pharmacology & therapeutics.
[57] W. Vogel,et al. Subfulminant hepatitis B after infliximab in Crohn's disease: need for HBV-screening? , 2006, World journal of gastroenterology.
[58] Y. Hiasa,et al. Anti-HBs-positive liver failure due to hepatitis B virus reactivation induced by rituximab. , 2006, Internal medicine.
[59] C. Wai,et al. Long-term results of liver transplant in patients with chronic viral hepatitis-related liver disease in Singapore. , 2006, Singapore medical journal.
[60] D. Thabut,et al. Model for end‐stage liver disease score and systemic inflammatory response are major prognostic factors in patients with cirrhosis and acute functional renal failure , 2007, Hepatology.
[61] K. Madan,et al. Hepatitis E virus (HEV) infection in patients with cirrhosis is associated with rapid decompensation and death. , 2007, Journal of hepatology.
[62] K. Shiraki,et al. Lamivudine for treatment of spontaneous exacerbation and reactivation after immunosuppressive therapy in patients with hepatitis B virus infection. , 2007, Hepato-gastroenterology.
[63] C. Wai,et al. MARS®: a futile tool in centres without active liver transplant support , 2007, Liver international : official journal of the International Association for the Study of the Liver.
[64] Tailin Wang,et al. Characteristics of acute and sub‐acute liver failure in China: nomination, classification and interval , 2007, Journal of gastroenterology and hepatology.
[65] R. Jalan,et al. Neutrophil dysfunction in alcoholic hepatitis superimposed on cirrhosis is reversible and predicts the outcome , 2007, Hepatology.
[66] Roger Williams,et al. Increasing dimethylarginine levels are associated with adverse clinical outcome in severe alcoholic hepatitis , 2007, Hepatology.
[67] H. Kohrt,et al. Antiviral prophylaxis for chemotherapy-induced reactivation of chronic hepatitis B virus infection. , 2007, Clinics in liver disease.
[68] M. Hussain,et al. Actin‐free Gc globulin: A rapidly assessed biomarker of organ dysfunction in acute liver failure and cirrhosis , 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[69] Pre-transplant optimization by Molecular Adsorbent Recirculating System in patients with severely decompensated chronic liver disease. , 2007, Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology.
[70] A. Lok,et al. Outcomes of patients with hepatitis B who developed antiviral resistance while on the liver transplant waiting list. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[71] Roger Williams,et al. Inflammation is an important determinant of levels of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine (ADMA) in acute liver failure , 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[72] Ramon Planas,et al. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis. , 2007, Gastroenterology.
[73] E. Masini,et al. ADMA correlates with portal pressure in patients with compensated cirrhosis , 2007, European journal of clinical investigation.
[74] J. Kao,et al. Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[75] C. Chiu,et al. Rituximab-induced hepatitis C virus reactivation after spontaneous remission in diffuse large B-cell lymphoma. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[76] B. Sharma,et al. Hemodynamic Studies in Acute-on-Chronic Liver Failure , 2009, Digestive Diseases and Sciences.
[77] 草野 浩治,et al. AASLD position paper: the management of acute liver failure (特集 救急診療ガイドライン) -- (海外のガイドライン) , 2008 .
[78] C. Hsiung,et al. A revisit of prophylactic lamivudine for chemotherapy‐associated hepatitis B reactivation in non‐Hodgkin's lymphoma: A randomized trial , 2008, Hepatology.
[79] M. Kumar,et al. Hepatitis E virus as an etiology of acute exacerbation of previously unrecognized asymptomatic patients with hepatitis B virus‐related chronic liver disease , 2008, Journal of gastroenterology and hepatology.
[80] 231 ACUTE ON CHRONIC LIVER FAILURE – ANALYSIS OF TWO DISTINCT LIVER HISTOLOGICAL PATTERNS , 2008 .
[81] William M. Lee,et al. Acute liver failure: Summary of a workshop , 2007, Hepatology.
[82] F. Zoulim,et al. Hepatitis B: reflections on the current approach to antiviral therapy. , 2008, Journal of hepatology.
[83] L. Paitoonpong,et al. Immunological response to hepatitis B vaccination in patients with AIDS and virological response to highly active antiretroviral therapy , 2008, Scandinavian journal of infectious diseases.
[84] R. Chung,et al. Bacterial, Parasitic, and Fungal Infections of the Liver, Including Liver Abscess , 2010 .